A Noninvasive Method to Measure Splanchnic Glucose Uptake After Oral Glucose Administration

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1995 May 1

PMID 7738188

Citations 19

Authors

B Ludvik

J J Nolan

A Roberts

J Baloga

M Joyce

J M Bell

J M Olefsky

Affiliations

Soon will be listed here.

Abstract

We have developed a noninvasive method to estimate splanchnic glucose uptake (SGU) in humans (oral glucose clamp technique [OG-CLAMP]), which combines a hyperinsulinemic clamp with an oral glucose load (oral glucose tolerance test). We validated this method in 12 nondiabetic subjects using hepatic vein catheterization (HVC) during an oral glucose tolerance test. During HVC, splanchnic blood flow increased from 1,395 +/- 64 to 1,935 +/- 109 ml/min, returning to basal after 180 min and accounted for 45 +/- 7% of SGU in lean and 19 +/- 5% in obese subjects (P < 0.05). SGU estimated during the OG-CLAMP was 22 +/- 2% of the glucose load, and this was significantly correlated (r = 0.90, P < 0.0001) with SGU (35 +/- 4%) and with first pass SGU (24 +/- 3%; r = 0.83, P < 0.001) measured during HVC. SGU was higher in obese than in lean subjects during OG-CLAMP (27 +/- 1% vs 18 +/- 3%, P < 0.01) and HVC (44 +/- 4% vs 26 +/- 5%, P < 0.05). In conclusion, SGU during the OG-CLAMP is well correlated to SGU measured during HVC. An increase in splanchnic blood flow is a major contributor to SGU in lean subjects. SGU is increased in obese subjects as measured by both methods.

Citing Articles

Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models.

Berton M, Bettonte S, Stader F, Battegay M, Marzolini C Clin Pharmacokinet. 2022; 61(9):1251-1270.

PMID: 35699913 PMC: 9439993. DOI: 10.1007/s40262-022-01132-3.

Exercise-Induced Improvements to Whole Body Glucose Metabolism in Type 2 Diabetes: The Essential Role of the Liver.

Warner S, Yao M, Cason R, Winnick J Front Endocrinol (Lausanne). 2020; 11:567.

PMID: 32982968 PMC: 7484211. DOI: 10.3389/fendo.2020.00567.

Aerobic exercise training improves hepatic and muscle insulin sensitivity, but reduces splanchnic glucose uptake in obese humans with type 2 diabetes.

Gregory J, Muldowney J, Engelhardt B, Tyree R, Marks-Shulman P, Silver H Nutr Diabetes. 2019; 9(1):25.

PMID: 31474750 PMC: 6717736. DOI: 10.1038/s41387-019-0090-0.

Effects of a novel selective peroxisome proliferator-activated receptor-α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance.

Matsuba I, Matsuba R, Ishibashi S, Yamashita S, Arai H, Yokote K J Diabetes Investig. 2018; 9(6):1323-1332.

PMID: 29603684 PMC: 6215940. DOI: 10.1111/jdi.12845.

Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.

Irimia J, Meyer C, Segvich D, Surendran S, DePaoli-Roach A, Morral N J Biol Chem. 2017; 292(25):10455-10464.

PMID: 28483921 PMC: 5481557. DOI: 10.1074/jbc.M117.786525.

References

Prager R, Wallace P, Olefsky J . In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest. 1986; 78(2):472-81. PMC: 423584. DOI: 10.1172/JCI112599. View

Cummins A . Absorption of glucose and methionine from the human intestine; the influence of the glucose concentration in the blood and in the intestinal lumen. J Clin Invest. 1952; 31(10):928-37. PMC: 436493. DOI: 10.1172/JCI102681. View

Kelley D, Mitrakou A, Marsh H, Schwenk F, Benn J, Sonnenberg G . Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest. 1988; 81(5):1563-71. PMC: 442590. DOI: 10.1172/JCI113489. View

Myers S, Hendrick G, Williams P, Triebwasser K, Floyd B, Cherrington A . Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes. 1990; 39(1):87-95. DOI: 10.2337/diacare.39.1.87. View

Butler P, Rizza R . Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes. 1991; 40(1):73-81. View

Gasic S, Kleinbloesem C, Heinz G, Waldhausl W . Contribution of splanchnic and peripheral vascular tissues to the disposal of angiotensin-II and to regional conversion rates of angiotensin-I: a pilot study in humans. J Cardiovasc Pharmacol. 1991; 17(4):615-20. DOI: 10.1097/00005344-199104000-00014. View

Radziuk J . Tracer methods and the metabolic disposal of a carbohydrate load in man. Diabetes Metab Rev. 1987; 3(1):231-67. DOI: 10.1002/dmr.5610030111. View

Ferrannini E, Simonson D, Katz L, Reichard Jr G, Bevilacqua S, Barrett E . The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism. 1988; 37(1):79-85. DOI: 10.1016/0026-0495(88)90033-9. View

FELIG P, Wahren J, Hendler R . Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes. 1978; 27(2):121-6. DOI: 10.2337/diab.27.2.121. View

10.

Unger R, EISENTRAUT A, MCCALL M, Madison L . Glucagon antibodies and an immunoassay for glucagon. J Clin Invest. 1961; 40:1280-9. PMC: 290840. DOI: 10.1172/JCI104357. View

11.

Bhathena S, Timmers K, Oie H, Voyles N, RECANT L . Cytosolic insulin-degrading activity in islet-derived tumor cell lines and in normal rat islets. Diabetes. 1985; 34(2):121-8. DOI: 10.2337/diab.34.2.121. View

12.

Ferrannini E, Wahren J, FELIG P, DeFronzo R . The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism. 1980; 29(1):28-35. DOI: 10.1016/0026-0495(80)90094-3. View

13.

Consoli A . Role of liver in pathophysiology of NIDDM. Diabetes Care. 1992; 15(3):430-41. DOI: 10.2337/diacare.15.3.430. View

14.

Horwitz D, Starr J, Mako M, BLACKARD W, Rubenstein A . Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest. 1975; 55(6):1278-83. PMC: 301883. DOI: 10.1172/JCI108047. View

15.

Cherrington A, Pagliassotti M, Myers S, McGuinness O . Factors which regulate net hepatic glucose uptake in vivo. JPEN J Parenter Enteral Nutr. 1991; 15(3):71S-73S. DOI: 10.1177/014860719101500371S. View

16.

Pagliassotti M, Cherrington A . Regulation of net hepatic glucose uptake in vivo. Annu Rev Physiol. 1992; 54:847-60. DOI: 10.1146/annurev.ph.54.030192.004215. View

17.

Radziuk J, McDonald T, Rubenstein D, Dupre J . Initial splanchnic extraction of ingested glucose in normal man. Metabolism. 1978; 27(6):657-69. DOI: 10.1016/0026-0495(78)90003-3. View

18.

Molina J, Baron A, Edelman S, Brechtel G, Wallace P, Olefsky J . Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol. 1990; 258(1 Pt 1):E16-23. DOI: 10.1152/ajpendo.1990.258.1.E16. View

19.

Olefsky J . LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes. 1981; 30(2):148-62. DOI: 10.2337/diab.30.2.148. View

20.

Olefsky J, Kolterman O . Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med. 1981; 70(1):151-68. DOI: 10.1016/0002-9343(81)90422-8. View